US Patent Issued to INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE), INSTITUT PASTEUR DE LILLE, UNIVERSITE DE LILLE 1 SCIENCES ET TECHNOLOGIES, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS), UNIVERSITE DE DROIT ET DE LA SANTE DE LILLE 2 on July 15 for "Treatment of acute exacerbations of chronic obstructive pulmonary disease by antagonism of the IL-20R" (French Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,358,977, issued on July 15, was assigned to INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (Paris), INSTITUT PASTEUR DE LILLE (Lille, France), UNIVERSITE DE LILLE 1 SCIENCES ET TECHNOLOGIES (Villeneuce d'Ascq, France), CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (Paris) and UNIVERSITE DE DROIT ET DE LA SANTE DE LILLE 2 (Lille, France).

"Treatment of acute exacerbations of chronic obstructive pulmonary disease by antagonism of the IL-20R" was invented by Philippe Gosset (Lille, France), Muriel Pichavant (Lille, France), Magdiel Perez-Cruz (Lille, France) and Bachirou Kone (Lille, France).

According to the abstract* released by the U.S. Patent & Trademark Of...